Clin2
NCT07419594Possibly a fitRecruiting

Estradiol and Intrusive Memories Study

PTSDIntrusive MemoriesIntrusion SymptomTraumaIntrusion

Treatments studied

Part of Injuries & trauma, Mental health clinical trials.

This study tests whether a single dose of estradiol (a hormone) can reduce intrusive memories in healthy women. It aims to see if this hormone can help prevent distressing memories from forming after a stressful event.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
273 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are a healthy woman without any current or past mental health conditions.
  • You speak German at a B1 level or higher.
  • You are not taking any medications (birth control pills are okay, but you cannot be on them for this trial).
  • You are not currently pregnant or breastfeeding.
  • You are not in the early (follicular) phase of your menstrual cycle.
  • You have not experienced a traumatic event like sexual abuse or rape.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07499440Recruiting· Phase 2
Testing a new medicine, HB-1, for PTSD

This trial tests an experimental medicine, HB-1, as a potential treatment for PTSD. It is a 8-week study to see if the medicine is safe and if it reduces PTSD symptoms. You must have a stable medication routine and be willing to take the study pill daily.

Bruce, Australian Capital Territory
NCT04452500Recruiting· Phase 2
Study drug for PTSD symptoms in Veterans

This trial tests a study medicine that blocks the effects of cortisol (a stress hormone) to reduce PTSD symptoms in Veterans. It’s meant for people with ongoing PTSD symptoms and stable treatments, and it closely checks safety because the medicine can affect sleep, mood, and heart rhythm.

Tuscaloosa, Alabama
NCT06902974Recruiting· Phase 2
Psilocybin therapy for PTSD from sexual assault

This trial tests whether psilocybin, a psychedelic drug given in a supportive therapy setting, can help women heal from post-traumatic stress disorder (PTSD) caused by a sexual assault that happened 6 or more months ago. You'll receive the drug during supervised sessions and attend therapy visits to see if it reduces your PTSD symptoms.

Rockville, Maryland
NCT06127342Recruiting
Exercise and emotional learning for PTSD

This study tests whether exercise can help people with PTSD learn to feel safer in their bodies. You will do some exercise sessions and emotional learning tasks, and have an MRI brain scan to see how your brain changes.

Lexington, Kentucky
NCT07737613Not yet recruiting· Early Phase 1
Estrogen's effects on brain fear learning in menopause

This trial tests whether a single dose of estradiol (a form of estrogen) changes how the brain processes fear. It may help understand why menopause affects emotional health.

NCT05282277Recruiting· Phase 4
Estradiol to improve brain and reward changes in midlife women

This study tests whether a hormone called estradiol (given as a patch and pill) changes how the brain and body respond to reward in some midlife women with low pleasure and/or psychosis symptoms during menopause transition. It may help researchers understand whether estrogen treatment can improve mood-related “reward” function in this group.

Chapel Hill, North Carolina

Hear when a new Trauma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.